108 related articles for article (PubMed ID: 16886595)
1. Modulating ICBP90 to suppress human ribonucleotide reductase M2 induction restores sensitivity to hydroxyurea cytotoxicity.
Un F; Qi C; Prosser M; Wang N; Zhou B; Bronner C; Yen Y
Anticancer Res; 2006; 26(4B):2761-7. PubMed ID: 16886595
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the R2 subunit of ribonucleotide reductase in human nasopharyngeal cancer cells reduces radiosensitivity.
Kuo ML; Hwang HS; Sosnay PR; Kunugi KA; Kinsella TJ
Cancer J; 2003; 9(4):277-85. PubMed ID: 12967138
[TBL] [Abstract][Full Text] [Related]
3. Time and sequence dependence of hydroxyurea in combination with gemcitabine in human KB cells.
Zhou B; Mi S; Mo X; Shih J; Tsai J; Hu E; Hsu M; Kay K; Yen Y
Anticancer Res; 2002; 22(3):1369-77. PubMed ID: 12168813
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition.
Arima Y; Hirota T; Bronner C; Mousli M; Fujiwara T; Niwa S; Ishikawa H; Saya H
Genes Cells; 2004 Feb; 9(2):131-42. PubMed ID: 15009091
[TBL] [Abstract][Full Text] [Related]
5. Genomic structure and chromosomal mapping of the gene coding for ICBP90, a protein involved in the regulation of the topoisomerase IIalpha gene expression.
Hopfner R; Mousli M; Garnier JM; Redon R; du Manoir S; Chatton B; Ghyselinck N; Oudet P; Bronner C
Gene; 2001 Mar; 266(1-2):15-23. PubMed ID: 11290415
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of ICBP90 contributes to doxorubicin resistance.
Wang J; Song Y; Xu S; Zhang Q; Li Y; Tang D; Jin S
Eur J Pharmacol; 2011 Apr; 656(1-3):33-8. PubMed ID: 21296067
[TBL] [Abstract][Full Text] [Related]
7. Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro.
Morikawa T; Hino R; Uozaki H; Maeda D; Ushiku T; Shinozaki A; Sakatani T; Fukayama M
Hum Pathol; 2010 Dec; 41(12):1742-8. PubMed ID: 20825972
[TBL] [Abstract][Full Text] [Related]
8. Determination of deoxyribonucleoside triphosphate pool sizes in ribonucleotide reductase cDNA transfected human KB cells.
Zhou BS; Ker R; Ho R; Yu J; Zhao YR; Shih J; Yen Y
Biochem Pharmacol; 1998 May; 55(10):1657-65. PubMed ID: 9634002
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of ribonucleotide reductase in transfected human KB cells increases their resistance to hydroxyurea: M2 but not M1 is sufficient to increase resistance to hydroxyurea in transfected cells.
Zhou BS; Hsu NY; Pan BC; Doroshow JH; Yen Y
Cancer Res; 1995 Mar; 55(6):1328-33. PubMed ID: 7882331
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of ICBP90, a novel CCAAT-binding protein, overcomes cell contact inhibition by forcing topoisomerase II alpha expression.
Hopfner R; Mousli M; Oudet P; Bronner C
Anticancer Res; 2002; 22(6A):3165-70. PubMed ID: 12530060
[TBL] [Abstract][Full Text] [Related]
11. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.
Zhou B; Liu X; Mo X; Xue L; Darwish D; Qiu W; Shih J; Hwu EB; Luh F; Yen Y
Cancer Res; 2003 Oct; 63(20):6583-94. PubMed ID: 14583450
[TBL] [Abstract][Full Text] [Related]
12. TCR pathway involves ICBP90 gene down-regulation via E2F binding sites.
Abbady AQ; Bronner C; Bathami K; Muller CD; Jeanblanc M; Mathieu E; Klein JP; Candolfi E; Mousli M
Biochem Pharmacol; 2005 Aug; 70(4):570-9. PubMed ID: 15964557
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human cancer cell growth by inducible expression of human ribonucleotide reductase antisense cDNA.
Chen S; Zhou B; He F; Yen Y
Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):111-6. PubMed ID: 10805162
[TBL] [Abstract][Full Text] [Related]
14. Ribonucleotide reductase activity in hydroxyurea-resistant herpesvirus replication.
Cohen JC; Henry BE; Randall CC; O'Callaghan DJ
Proc Soc Exp Biol Med; 1977 Jul; 155(3):395-9. PubMed ID: 195286
[No Abstract] [Full Text] [Related]
15. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression.
Hopfner R; Mousli M; Jeltsch JM; Voulgaris A; Lutz Y; Marin C; Bellocq JP; Oudet P; Bronner C
Cancer Res; 2000 Jan; 60(1):121-8. PubMed ID: 10646863
[TBL] [Abstract][Full Text] [Related]
16. The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle.
Jeanblanc M; Mousli M; Hopfner R; Bathami K; Martinet N; Abbady AQ; Siffert JC; Mathieu E; Muller CD; Bronner C
Oncogene; 2005 Nov; 24(49):7337-45. PubMed ID: 16007129
[TBL] [Abstract][Full Text] [Related]
17. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain.
Unoki M; Nishidate T; Nakamura Y
Oncogene; 2004 Oct; 23(46):7601-10. PubMed ID: 15361834
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hepatitis B virus replication by targeting ribonucleotide reductase M2 protein.
Liu X; Xu Z; Hou C; Wang M; Chen X; Lin Q; Song R; Lou M; Zhu L; Qiu Y; Chen Z; Yang C; Zhu W; Shao J
Biochem Pharmacol; 2016 Mar; 103():118-28. PubMed ID: 26774458
[TBL] [Abstract][Full Text] [Related]
19. ATR-CHK1-E2F3 signaling transactivates human ribonucleotide reductase small subunit M2 for DNA repair induced by the chemical carcinogen MNNG.
Gong C; Liu H; Song R; Zhong T; Lou M; Wang T; Qi H; Shen J; Zhu L; Shao J
Biochim Biophys Acta; 2016 Apr; 1859(4):612-26. PubMed ID: 26921499
[TBL] [Abstract][Full Text] [Related]
20. dNTP deficiency induced by HU via inhibiting ribonucleotide reductase affects neural tube development.
Guan Z; Wang X; Dong Y; Xu L; Zhu Z; Wang J; Zhang T; Niu B
Toxicology; 2015 Feb; 328():142-51. PubMed ID: 25527867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]